Serum seeks DCGI approval for booster dose in India
The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India
The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
This strategic collaboration will enable continued innovation in cancer care
It has been built at a cost of Rs 19.5 crores through internal accruals of the Malabar Institute of Medical Sciences (MIMS)
Subscribe To Our Newsletter & Stay Updated